Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

Fibrosis plays an important role in the pathogenesis of long-term diabetic complications and contributes to the development of cardiac and renal dysfunction. The aim of this experimental study, performed in a long-term rat model, which resembles type 1 diabetes mellitus, was to investigate the role of soluble Klotho (sKlotho), advanced glycation end products (AGEs)/receptor for AGEs (RAGE), fibrotic Wnt/β-catenin pathway, and pro-fibrotic pathways in kidney and heart. Diabetes was induced by streptozotocin. Glycaemia was maintained by insulin administration for 24 weeks. Serum and urine sKlotho, AGEs, soluble RAGE (sRAGE) and biochemical markers were studied. The levels of Klotho, RAGEs, ADAM10, markers of fibrosis (collagen deposition, fibronectin, TGF-β1, and Wnt/β-catenin pathway), hypertrophy of the kidney and/or heart were analysed. At the end of study, diabetic rats showed higher levels of urinary sKlotho, AGEs and sRAGE and lower serum sKlotho compared with controls without differences in the renal Klotho expression. A significant positive correlation was found between urinary sKlotho and AGEs and urinary albumin/creatinine ratio (uACR). Fibrosis and RAGE levels were significantly higher in the heart without differences in the kidney of diabetic rats compared to controls. The results also suggest the increase in sKlotho and sRAGE excretion may be due to polyuria in the diabetic rats.

[1]  Sha-Sha Li,et al.  The controversy of klotho as a potential biomarker in chronic kidney disease , 2022, Frontiers in Pharmacology.

[2]  Endeshaw Chekol Abebe,et al.  Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications , 2022, Frontiers in Molecular Biosciences.

[3]  A. Zubkiewicz-Kucharska,et al.  Soluble Klotho Is Decreased in Children With Type 1 Diabetes and Correlated With Metabolic Control , 2021, Frontiers in Endocrinology.

[4]  W. Rathmann,et al.  Quantifying the underestimation of projected global diabetes prevalence by the International Diabetes Federation (IDF) Diabetes Atlas , 2021, BMJ Open Diabetes Research & Care.

[5]  M. Saleem,et al.  Role of Klotho in Hyperglycemia: Its Levels and Effects on Fibroblast Growth Factor Receptors, Glycolysis, and Glomerular Filtration , 2021, International journal of molecular sciences.

[6]  T. Salvatore,et al.  The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms , 2021, Frontiers in Medicine.

[7]  J. Erusalimsky The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes , 2021, Redox biology.

[8]  K. Birkeland,et al.  Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study , 2021, Diabetes Care.

[9]  Zhongjie Sun,et al.  Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway. , 2020, Circulation research.

[10]  J. Marshall,et al.  Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes , 2020, Molecules.

[11]  Akshay S. Desai,et al.  NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus , 2020, Journal of the American Heart Association.

[12]  Jinghong Zhao,et al.  The Protective Role of Klotho in CKD-Associated Cardiovascular Disease , 2020, Kidney Diseases.

[13]  N. Vaziri,et al.  Wnt signaling pathway in aging-related tissue fibrosis and therapies , 2020, Ageing Research Reviews.

[14]  A. Banerjee,et al.  Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study , 2020, Diabetes, obesity & metabolism.

[15]  A. Giovino,et al.  Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects , 2020, Oxidative medicine and cellular longevity.

[16]  A. Papagianni,et al.  Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis , 2019, BMC Nephrology.

[17]  Ya Wang,et al.  Exogenous H2S mitigates myocardial fibrosis in diabetic rats through suppression of the canonical Wnt pathway , 2019, International journal of molecular medicine.

[18]  Youhua Liu,et al.  Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome. , 2019, Kidney international.

[19]  Lin Sun,et al.  A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy. , 2019, Advances in experimental medicine and biology.

[20]  M. Kuro-o The Klotho proteins in health and disease , 2018, Nature Reviews Nephrology.

[21]  T. Yoo,et al.  Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy. , 2018, American journal of physiology. Renal physiology.

[22]  K. Prasad Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases? , 2018, Molecular and Cellular Biochemistry.

[23]  M. Sánchez-Niño,et al.  Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease , 2018, Diabetes Care.

[24]  Z. Ni,et al.  Klotho Reduces Necroptosis by Targeting Oxidative Stress Involved in Renal Ischemic-Reperfusion Injury , 2018, Cellular Physiology and Biochemistry.

[25]  Masaya Takahashi,et al.  Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. , 2017, Kidney international.

[26]  Y. Higashimoto,et al.  RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy , 2017, Diabetes.

[27]  M. Bianchi,et al.  The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection. , 2017, Biochimica et biophysica acta. General subjects.

[28]  Techung Lee,et al.  sFRP2 activates Wnt/β-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling. , 2016, American journal of physiology. Cell physiology.

[29]  N. Yılmaz,et al.  Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria , 2016, Journal of Investigative Medicine.

[30]  S. Sidhu,et al.  Renal Production, Uptake, and Handling of Circulating αKlotho. , 2016, Journal of the American Society of Nephrology : JASN.

[31]  J. Navarro-González,et al.  Klotho in cardiovascular disease: Current and future perspectives. , 2015, World journal of biological chemistry.

[32]  M. Mohammadi,et al.  The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  J. Stewart,et al.  Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart. , 2014, World journal of diabetes.

[34]  Q. Yuan,et al.  The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. , 2014, Diabetes research and clinical practice.

[35]  B. Lanske,et al.  The kidney is the principal organ mediating klotho effects. , 2014, Journal of the American Society of Nephrology : JASN.

[36]  Y. Nabeshima,et al.  Reduced Renal α-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism , 2014, PloS one.

[37]  Youhua Liu,et al.  Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling. , 2013, Journal of the American Society of Nephrology : JASN.

[38]  M. Kuro-o,et al.  Renal and extrarenal actions of Klotho. , 2013, Seminars in nephrology.

[39]  C. Bondor,et al.  Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. , 2012, Clinical biochemistry.

[40]  Oliver Distler,et al.  Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis , 2012, Nature Communications.

[41]  D. Brazil,et al.  CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: Implications for the pathogenesis of diabetic nephropathy , 2011, FEBS letters.

[42]  Jai Radhakrishnan,et al.  Pathologic classification of diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[43]  C. Kuo,et al.  Augmented Wnt Signaling in a Mammalian Model of Accelerated Aging , 2007, Science.

[44]  L. Leng,et al.  Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes , 2006, Diabetologia.

[45]  H. Kaneto,et al.  Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. , 2005, Diabetes care.

[46]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.